Jacob A Gordon
Overview
Explore the profile of Jacob A Gordon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bashi A, Coker E, Bulusu K, Jaaks P, Crafter C, Lightfoot H, et al.
Cancer Discov
. 2024 Mar;
14(5):846-865.
PMID: 38456804
Significance: We present the largest cancer drug combination screen published to date with 7 × 7 concentration response matrices for 109 combinations in more than 750 cell lines, complemented by...
2.
Pandey M, Cuddihy G, Gordon J, Cox M, Wasan K
Pharmaceutics
. 2021 Sep;
13(9).
PMID: 34575583
There have been several studies that have linked elevated scavenger receptor class b type 1 (SR-B1) expression and activity to the development and progression of castration-resistant prostate cancer (CRPC). SR-B1...
3.
Eyford B, Singh C, Abraham T, Munro L, Choi K, Hill T, et al.
Front Mol Biosci
. 2021 May;
8:687587.
PMID: 34026851
[This corrects the article DOI: 10.3389/fmolb.2021.611367.].
4.
Eyford B, Singh C, Abraham T, Munro L, Choi K, Hill T, et al.
Front Mol Biosci
. 2021 Apr;
8:611367.
PMID: 33869275
The blood-brain barrier (BBB) hinders the distribution of therapeutics intended for treatment of neuroinflammation (NI) of the central nervous system. A twelve-amino acid peptide that transcytoses the BBB, termed MTfp,...
5.
McIntyre W, Healey J, Bhatnagar A, Wang P, Gordon J, Baranchuk A, et al.
Europace
. 2019 Jul;
21(8):1159-1166.
PMID: 31292622
Aims: To evaluate the efficacy and safety of vernakalant for the cardioversion of atrial fibrillation (AF). Methods And Results: We reviewed the literature for randomized trials that compared vernakalant to...
6.
Gordon J, Noble J, Midha A, Derakhshan F, Wang G, Adomat H, et al.
Cancer Res
. 2019 May;
79(13):3320-3331.
PMID: 31064850
Aberrant cholesterol metabolism is increasingly appreciated to be essential for prostate cancer initiation and progression. Transcript expression of the high-density lipoprotein-cholesterol receptor scavenger receptor B1 (SR-B1) is elevated in primary...
7.
Gordon J, Buonerba C, Pond G, Crona D, Gillessen S, Lucarelli G, et al.
Oncotarget
. 2018 May;
9(28):19861-19873.
PMID: 29731989
Background: Statins may potentiate the effects of anti-hormonal agents for metastatic castration-resistant prostate cancer (mCRPC) through further disruption of essential steroidogenic processes. We investigated the effects of statin use on...